These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2294999)

  • 1. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin.
    Jakubowski JA; Maraganore JM
    Blood; 1990 Jan; 75(2):399-406. PubMed ID: 2294999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E; Lunven C; Gauffeny C; Roome NO; Berry CN
    Thromb Haemost; 1998 Nov; 80(5):840-4. PubMed ID: 9843181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptides.
    Church FC; Phillips JE; Woods JL
    J Biol Chem; 1991 Jun; 266(18):11975-9. PubMed ID: 2050691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet functions in recombinant hirudin-anticoagulated blood.
    Glusa E; Markwardt F
    Haemostasis; 1990; 20(2):112-8. PubMed ID: 2363746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory assays for the evaluation of recombinant hirudin.
    Walenga JM; Hoppensteadt D; Koza M; Wallock M; Pifarre R; Fareed J
    Haemostasis; 1991; 21 Suppl 1():49-63. PubMed ID: 1894197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future alternatives to heparin: low-molecular-weight heparin and hirudin.
    Donayre CE; Ouriel K; Rhee RY; Shortell CK
    J Vasc Surg; 1992 Apr; 15(4):675-82. PubMed ID: 1313932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin effects of native and recombinant hirudins.
    Markwardt F; Stürzebecher J; Glusa E
    Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
    Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
    Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant activity of synthetic hirudin peptides.
    Maraganore JM; Chao B; Joseph ML; Jablonski J; Ramachandran KL
    J Biol Chem; 1989 May; 264(15):8692-8. PubMed ID: 2722794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets.
    Jandrot-Perrus M; Huisse MG; Krstenansky JL; Bezeaud A; Guillin MC
    Thromb Haemost; 1991 Sep; 66(3):300-5. PubMed ID: 1746000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hirudisins. Hirudin-derived thrombin inhibitors with disintegrin activity.
    Knapp A; Degenhardt T; Dodt J
    J Biol Chem; 1992 Dec; 267(34):24230-4. PubMed ID: 1447173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation, sensitivity to prostaglandin E1 and thromboxane A2 release in recombinant hirudin- and heparin-anticoagulated blood.
    Viigimaa M; Tsikas D; Frölich JC
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):259-61. PubMed ID: 8735834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular tissue factor stimulates thromboxane synthesis in human platelets via thrombin generation.
    Ardaillou R; Bens M; Edgington TS
    Kidney Int; 1992 Feb; 41(2):361-8. PubMed ID: 1552709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT; Paul W; Emerson M; Cicala C; Page CP
    Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S; Muntean W; Leis HJ
    Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thrombin inhibitors on platelet functions: comparative analysis of DuP 714 and hirudin.
    Reilly TM; Knabb RM; Hassell SM; Bozarth JM; Forsythe MS; Mayo MC; Racanelli AL; Mousa SA
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):513-7. PubMed ID: 1450317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.
    Hafner G; Rupprecht HJ; Luz M; Terres W; Schindel F; Friesen HJ; Heinrichs H; Jessel A; Meyer J; Prellwitz W
    Eur Heart J; 1996 Aug; 17(8):1207-15. PubMed ID: 8869862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition.
    Mo W; Zhang YL; Chen HS; Wang LS; Song HY
    J Thromb Thrombolysis; 2009 Aug; 28(2):230-7. PubMed ID: 18998199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.